124 related articles for article (PubMed ID: 21855183)
1. Novel C-4'' modified azithromycin analogs with remarkably enhanced activity against erythromycin-resistant Streptococcus pneumoniae: the synthesis and antimicrobial evaluation.
Ma X; Zhang L; Wang R; Cao J; Liu C; Fang Y; Wang J; Ma S
Eur J Med Chem; 2011 Oct; 46(10):5196-205. PubMed ID: 21855183
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antibacterial activity of novel 11,12-cyclic carbonate azithromycin 4''-O-carbamate derivatives.
Ma C; Liu Z; Song H; Jiang R; He F; Ma S
J Antibiot (Tokyo); 2010 Jan; 63(1):3-8. PubMed ID: 19911029
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of novel 15-membered macrolide derivatives: 4''-carbamate, 11,12-cyclic carbonate-4''-carbamate and 11,4''-di-O-arylcarbamoyl analogs of azithromycin.
Ma S; Ma R; Liu Z; Ma C; Shen X
Eur J Med Chem; 2009 Oct; 44(10):4010-20. PubMed ID: 19464769
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial evaluation of novel 11,4″-disubstituted azithromycin analogs with greatly improved activity against erythromycin-resistant bacteria.
Li X; Ma S; Yan M; Wang Y; Ma S
Eur J Med Chem; 2013 Jan; 59():209-17. PubMed ID: 23229056
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of novel 3-O-carbamoyl derivatives of clarithromycin and 11,12-cyclic carbonate azithromycin.
Zhang L; Song L; Liu Z; Li H; Lu Y; Li Z; Ma S
Eur J Med Chem; 2010 Mar; 45(3):915-22. PubMed ID: 19945195
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of 4'',11-di-O-arylalkylcarbamoyl azithromycin derivatives.
Ma S; Jiao B; Liu Z; Wang H; Xian R; Zheng M; Lou H
Bioorg Med Chem Lett; 2009 Mar; 19(6):1698-701. PubMed ID: 19232491
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs.
Wang Y; Cong C; Chai WC; Dong R; Jia L; Song D; Zhou Z; Ma S
Bioorg Med Chem Lett; 2017 Aug; 27(16):3872-3877. PubMed ID: 28655423
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of novel 4''-O-carbamoyl erythromycin-A derivatives.
Qi Y; Jiao B; Ma X; Cui W; Ma S
Arch Pharm (Weinheim); 2010 Aug; 343(8):458-64. PubMed ID: 20803622
[TBL] [Abstract][Full Text] [Related]
9. Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes.
Ko KS; Song JH
J Infect Dis; 2004 Aug; 190(4):739-47. PubMed ID: 15272402
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
[TBL] [Abstract][Full Text] [Related]
11. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.
Gulay Z; Ozbek OA; Bicmen M; Gur D
Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial activity of new 4″-O-carbamates of 11,12-cyclic carbonate erythromycin A 6,9-imino ether.
Zhang L; Jiao B; Yang X; Liu L; Ma S
J Antibiot (Tokyo); 2011 Mar; 64(3):243-7. PubMed ID: 21245870
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains.
Ma S; Jiao B; Ju Y; Zheng M; Ma R; Liu L; Zhang L; Shen X; Ma C; Meng Y; Wang H; Qi Y; Ma X; Cui W
Eur J Med Chem; 2011 Feb; 46(2):556-66. PubMed ID: 21159410
[TBL] [Abstract][Full Text] [Related]
14. Azithromycin iv pharmacodynamic parameters predicting Streptococcus pneumoniae killing in epithelial lining fluid versus serum: an in vitro pharmacodynamic simulation.
Sevillano D; Alou L; Aguilar L; Echevarría O; Giménez MJ; Prieto J
J Antimicrob Chemother; 2006 Jun; 57(6):1128-33. PubMed ID: 16617063
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides.
Jia L; Yan M; Shen Y; Qin Y; Qiang S; Ma S
Bioorg Med Chem Lett; 2017 Aug; 27(16):3693-3697. PubMed ID: 28711353
[TBL] [Abstract][Full Text] [Related]
17. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
18. High clonal diversity in erythromycin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2000-07).
de la Pedrosa EG; Baquero F; Loza E; Nadal-Serrano JM; Fenoll A; Del Campo R; Cantón R
J Antimicrob Chemother; 2009 Dec; 64(6):1165-9. PubMed ID: 19837717
[TBL] [Abstract][Full Text] [Related]
19. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
Song JH; Chang HH; Suh JY; Ko KS; Jung SI; Oh WS; Peck KR; Lee NY; Yang Y; Chongthaleong A; Aswapokee N; Chiu CH; Lalitha MK; Perera J; Yee TT; Kumararasinghe G; Jamal F; Kamarulazaman A; Parasakthi N; Van PH; So T; Ng TK;
J Antimicrob Chemother; 2004 Mar; 53(3):457-63. PubMed ID: 14963068
[TBL] [Abstract][Full Text] [Related]
20. Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany.
van der Linden M; Al-Lahham A; Haupts S; Reinert RR
Antimicrob Agents Chemother; 2007 May; 51(5):1830-4. PubMed ID: 17325214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
